<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Microbiol</journal-id><journal-id journal-id-type="publisher-id">cmi</journal-id><journal-title>Cellular Microbiology</journal-title><issn pub-type="ppub">1462-5814</issn><issn pub-type="epub">1462-5822</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1111/j.1462-5822.2007.01035.x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dessing</surname><given-names>Mark C</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Florquin</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Paton</surname><given-names>James C</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name><surname>van der Poll</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><aff id="au1"><label>1</label><institution>Center of Infection and Immunity Amsterdam (CINIMA)</institution><addr-line>the Netherlands</addr-line></aff><aff id="au2"><label>2</label><institution>Center of Experimental and Molecular Medicine</institution><addr-line>the Netherlands</addr-line></aff><aff id="au3"><label>3</label><institution>Department of Pathology, Academic Medical Center, University of Amsterdam</institution><addr-line>the Netherlands</addr-line></aff><aff id="au4"><label>4</label><institution>School of Molecular and Biomedical Science, University of Adelaide</institution><addr-line>Adelaide, Australia</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><sup>*</sup>For correspondence. E-mail <email>m.c.dessing@amc.uva.nl</email>; Tel. (+31) 205665645; Fax (+31) 206977192.</corresp><fn><p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2008</year></pub-date><volume>10</volume><issue>1</issue><fpage>237</fpage><lpage>246</lpage><history><date date-type="received"><day>24</day><month>4</month><year>2007</year></date><date date-type="rev-recd"><day>09</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>17</day><month>7</month><year>2007</year></date></history><copyright-statement>&#x000a9; 2007 The Authors Journal compilation &#x000a9; 2007 Blackwell Publishing Ltd</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Toll-like receptors (TLRs) are pattern recognition receptors that recognize conserved molecular patterns expressed by pathogens. Pneumolysin, an intracellular toxin found in all <italic>Streptococcus pneumoniae</italic> clinical isolates, is an important virulence factor of the pneumococcus that is recognized by TLR4. Although TLR2 is considered the most important receptor for Gram-positive bacteria, our laboratory previously could not demonstrate a decisive role for TLR2 in host defence against pneumonia caused by a serotype 3 <italic>S. pneumoniae</italic>. Here we tested the hypothesis that in the absence of TLR2, <italic>S. pneumoniae</italic> can still be sensed by the immune system through an interaction between pneumolysin and TLR4. C57BL/6 wild-type (WT) and TLR2 knockout (KO) mice were intranasally infected with either WT <italic>S. pneumoniae</italic> D39 (serotype 2) or the isogenic pneumolysin-deficient <italic>S. pneumoniae</italic> strain D39 PLN. TLR2 did not contribute to antibacterial defence against WT <italic>S. pneumoniae</italic> D39. In contrast, pneumolysin-deficient <italic>S. pneumoniae</italic> only grew in lungs of TLR2 KO mice. TLR2 KO mice displayed a strongly reduced early inflammatory response in their lungs during pneumonia caused by both pneumolysin-producing and pneumolysin-deficient pneumococci. These data suggest that pneumolysin-induced TLR4 signalling can compensate for TLR2 deficiency during respiratory tract infection with <italic>S. pneumoniae.</italic></p></abstract></article-meta></front><body><sec><title>Introduction</title><p><italic>Streptococcus pneumoniae</italic> is the most common cause of community-acquired pneumonia (<xref ref-type="bibr" rid="b4">Bernstein, 1999</xref>; <xref ref-type="bibr" rid="b8">Campbell, 1999</xref>). Infections caused by <italic>S. pneumoniae</italic> are increasingly difficult to treat due to the emergence of antibiotic-resistant strains (<xref ref-type="bibr" rid="b30">Pikis <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="b35">Schreiber and Jacobs, 1995</xref>). Increased knowledge of the first interaction between <italic>S. pneumoniae</italic> and host immune cells may facilitate the development of novel prophylactic and therapeutic tools to combat pneumococcal infections. In this respect, Toll-like receptors (TLRs), a family of pattern recognition receptors that are capable of recognizing conserved molecular patterns expressed by pathogens, are of particular interest (<xref ref-type="bibr" rid="b19">Kawai and Akira, 2005</xref>; <xref ref-type="bibr" rid="b27">Paterson and Mitchell, 2006</xref>).</p><p>The pneumococcal cell wall consists of several proteins and enzymes that contribute to the virulence of the pathogen and the pathogenesis of pneumonia (<xref ref-type="bibr" rid="b17">Jedrzejas, 2001</xref>). Pneumolysin is an intracellular toxin found in <italic>S. pneumoniae</italic>, which is produced by all clinical isolates and is an important factor for the virulence of the pneumococcus (<xref ref-type="bibr" rid="b15">Hirst <italic>et al</italic>., 2004</xref>). Indeed, mice infected with a pneumolysin-deficient strain of <italic>S. pneumoniae</italic> showed a reduced lethality and a diminished inflammatory response compared with mice infected with a normal, pneumolysin-producing strain (<xref ref-type="bibr" rid="b6">Berry <italic>et al</italic>., 1989</xref>; <xref ref-type="bibr" rid="b3">Benton <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="b9">Canvin <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="b34">Rubins <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="b5">Berry and Paton, 2000</xref>; <xref ref-type="bibr" rid="b18">Kadioglu <italic>et al</italic>., 2002</xref>). At sublytic dose, pneumolysin affects polymorphonuclear cell activity, including respiratory burst, degranulation, chemotaxis and bactericidal activity (<xref ref-type="bibr" rid="b29">Paton and Ferrante, 1983</xref>). Furthermore, pneumolysin activates the classical pathway of complement and induces cytokine production by macrophages and monocytes (<xref ref-type="bibr" rid="b16">Houldsworth <italic>et al</italic>., 1994</xref>; <xref ref-type="bibr" rid="b28">Paton, 1996</xref>; <xref ref-type="bibr" rid="b10">Cockeran <italic>et al</italic>., 2002</xref>). At lytic dose, pneumolysin forms ring-shaped pores in cholesterol-containing cell membranes, which results in cell death (<xref ref-type="bibr" rid="b2">Alouf, 2000</xref>; <xref ref-type="bibr" rid="b13">Gilbert, 2002</xref>). Recent work has suggested that the immune system recognizes pneumolysin through TLR4 (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>). Both pneumolysin-induced cytokine production and pneumolysin-induced apoptosis are mediated through TLR4 (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>). In a model of nasopharyngeal colonization by <italic>S. pneumoniae</italic>, the interaction between pneumolysin and TLR4 was found to be essential for preventing invasive disease (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>). Our laboratory reported a protective role of TLR4 during infection of the lower respiratory tract by <italic>S. pneumoniae</italic>, demonstrating an enhanced growth of bacteria in lungs of TLR4-deficient mice (<xref ref-type="bibr" rid="b7">Branger <italic>et al</italic>., 2004</xref>).</p><p>Within the family of TLRs, TLR2 has been implicated as the major pattern recognition receptor for ligands derived from Gram-positive bacteria (<xref ref-type="bibr" rid="b39">Yoshimura <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b14">Han <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b36">Schroder <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b19">Kawai and Akira, 2005</xref>). However, our laboratory recently demonstrated that TLR2 does not play a key role in host resistance to pneumonia caused by a serotype 3 strain of <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). We here hypothesized that TLR2 knockout (KO) mice have an intact protective immune response against <italic>S. pneumoniae</italic>, because they are still capable of activating their immune system through an interaction between pneumolysin and TLR4. If this assumption is true, TLR2 KO mice would display a reduced antibacterial defence against pneumolysin-deficient <italic>S. pneumoniae</italic>, considering that these modified bacteria, devoid of a major TLR4 ligand, would primarily express TLR2 ligands. Therefore, in the present study we compared the response of TLR2 KO and wild-type (WT) mice during respiratory tract infection with WT and pneumolysin-deficient <italic>S. pneumoniae</italic>.</p></sec><sec><title>Results</title><sec><title>Toll-like receptor 2 does not contribute to host defence and pulmonary inflammation against pneumonia caused by WT <italic>S. pneumoniae</italic> D39</title><p>We previously showed that TLR2 KO mice are indistinguishable from WT mice with regard to bacterial outgrowth and mortality after intranasal infection with a serotype 3 <italic>S. pneumoniae</italic> strain (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). Considering that the pneumolysin-deficient strain used here is a serotype 2 (derived from <italic>S. pneumoniae</italic> D39), we first investigated the impact of TLR2 deficiency on the course of pneumonia caused by WT <italic>S. pneumoniae</italic> D39 (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). Mortality did not differ between TLR2 KO and WT mice after intranasal infection with <italic>S. pneumoniae</italic> D39; if anything, TLR2 KO mice displayed a slightly reduced mortality (62.5%) although the difference with WT mice (75% mortality) was not significant (<italic>P</italic> = 0.13; <xref ref-type="fig" rid="fig01">Fig. 1A</xref>). We next determined bacterial loads in whole lung homogenates at 24 and 48 h after infection, i.e. at time points just before the first mice started dying (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>). At both 24 and 48 h, bacterial loads were identical in lungs of TLR2 KO and WT mice. Together these data extend our earlier study using a serotype 3 <italic>S. pneumoniae</italic> strain (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>), showing that TLR2 does not contribute to a protective immune response during pneumonia caused by a serotype 2 pneumococcus.</p><fig id="fig01" position="float"><label>Fig. 1</label><caption><p>TLR2 does not contribute to host defence against WT <italic>S. pneumoniae</italic>. Survival (A) and bacterial outgrowth (B) of WT mice (closed symbols or bars) and TLR2 KO mice (open symbols or bars) with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> D39. Mortality was assessed four times daily for 14 days (<italic>n</italic> = 16 per group). Bacterial loads in WT mice and TLR2 KO mice were determined 24 and 48 h after infection. Data of bacterial loads are mean &#x000b1; SEM (<italic>n</italic> = 7&#x02013;8 per group at each time point).</p></caption><graphic xlink:href="cmi0010-0237-f1"/></fig></sec><sec><title>Toll-like receptor 2 (TLR2) deficiency modestly attenuates the inflammatory response induced by WT <italic>S. pneumoniae</italic> D39</title><p>Cytokines and chemokines play an important role in the antibacterial defence against bacterial pneumonia (<xref ref-type="bibr" rid="b26">Moore and Standiford, 2001</xref>; <xref ref-type="bibr" rid="b22">Knapp <italic>et al</italic>., 2005</xref>). We therefore determined the concentrations of tumour necrosis factor (TNF)-&#x003b1;, interleukin (IL)-1&#x003b2;, IL-10, macrophage inflammatory protein (MIP)-2 and cytokine-induced neutrophil chemoattractant (KC) in whole lung homogenates obtained 24 and 48 h after inoculation (<xref ref-type="table" rid="tbl1">Table 1</xref>). Although in general the pulmonary concentrations of these mediators were lower in TLR2 KO mice, the differences with WT mice were statistically significant only for KC (<italic>P</italic> &#x0003c; 0.005 at 24 and 48 h post infection) and IL-1&#x003b2; (<italic>P</italic> &#x0003c; 0.05 at 48 h). To further investigate lung inflammation, we determined pulmonary myeloperoxidase (MPO) levels, reflecting the whole-organ neutrophil content, in TLR2 KO mice and WT mice (<xref ref-type="table" rid="tbl1">Table 1</xref>). Similar to cytokine and chemokine levels, MPO concentrations were modestly lower in TLR2 KO, significantly so at 48 h post infection (<italic>P</italic> &#x0003c; 0.01). Moreover, total lung inflammation scores, determined from lung tissue slides prepared 24 and 48 h after infection with <italic>S. pneumoniae</italic> D39, were similar in WT and TLR2 KO mice (<xref ref-type="table" rid="tbl1">Table 1</xref>). Together, these data obtained with a serotype 2 pneumococcus confirm our earlier data generated with a serotype 3 <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>), establishing that TLR2 plays a modest role in the induction of a pulmonary inflammatory response to respiratory tract infection with WT <italic>S. pneumoniae</italic>.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Parameters of lung inflammation in TLR2 KO and WT mice 24 and 48 h after infection with WT <italic>S. pneumoniae</italic> D39.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">24 h</th><th align="center" colspan="2" rowspan="1">48 h</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><hr/></th><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1229 &#x000b1; 351</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1026 &#x000b1; 212</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">500 &#x000b1; 92</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">361 &#x000b1; 63</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4029 &#x000b1; 599</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3248 &#x000b1; 495</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2874 &#x000b1; 594</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1462 &#x000b1; 329<xref ref-type="table-fn" rid="tf1-1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">IL-10</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">62 &#x000b1; 23</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">48 &#x000b1; 14</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">123 &#x000b1; 51</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">72 &#x000b1; 13</td></tr><tr><td align="left" rowspan="1" colspan="1">MIP-2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5912 &#x000b1; 876</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5689 &#x000b1; 1039</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1447 &#x000b1; 177</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1182 &#x000b1; 243</td></tr><tr><td align="left" rowspan="1" colspan="1">KC</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5943 &#x000b1; 867</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2244 &#x000b1; 510<xref ref-type="table" rid="tbl1">**</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3481 &#x000b1; 339</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">695 &#x000b1; 90<xref ref-type="table" rid="tbl1">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">MPO</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7668 &#x000b1; 1123</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">6158 &#x000b1; 2317</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9183 &#x000b1; 2365</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4057 &#x000b1; 578<xref ref-type="table" rid="tbl1">***</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TLIS</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">16.7 &#x000b1; 0.9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">16.8 &#x000b1; 1.0</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">13.5 &#x000b1; 0.6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">15.5 &#x000b1; 0.8</td></tr></tbody></table><table-wrap-foot><fn><p>Mice were intranasally infected with 5 &#x000d7; 10<sup>7</sup> cfu WT <italic>S. pneumoniae</italic> D39; whole lung homogenates were obtained 24 and 48 h thereafter. Data are means &#x000b1; SEM (<italic>n</italic> = 6&#x02013;8 per group).</p></fn><fn id="tf1-1"><label>*</label><p><italic>P</italic> &#x0003c; 0.05 versus WT mice.</p></fn><fn id="tf1-2"><label>**</label><p><italic>P</italic> &#x0003c; 0.005 versus WT mice.</p></fn><fn id="tf1-3"><label>***</label><p><italic>P</italic> &#x0003c; 0.01 versus WT mice.</p></fn><fn><p>TNF-&#x003b1;, IL-1&#x003b2;, IL-10, MIP-2 and KC values are in pg ml<sup>&#x02212;1</sup>; MPO values are in ng ml<sup>&#x02212;1</sup>; TLIS (total lung inflammation score) in arbitrary units.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Toll-like receptor 2 limits the outgrowth of pneumolysin-deficient <italic>S. pneumoniae</italic> PLN</title><p>Having established that TLR2 is not essential for host defence against WT <italic>S. pneumoniae</italic> D39, we next infected TLR2 KO and WT mice with the isogenic mutant <italic>S. pneumoniae</italic> PLN (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). As expected (<xref ref-type="bibr" rid="b6">Berry <italic>et al</italic>., 1989</xref>), <italic>S. pneumoniae</italic> PLN was less virulent, in particular in WT mice. Only 23% of WT mice died during a 2 week follow-up, versus 38% of TLR2 KO mice (not significant for the difference between mouse strains; <italic>P</italic> = 0.29; <xref ref-type="fig" rid="fig02">Fig. 2A</xref>). Interestingly, TLR2 KO mice started to die after 3 days, whereas the first deaths among WT mice occurred after 5 days. To obtain insight in the growth of <italic>S. pneumoniae</italic> PLN during the infection (i.e. before the first mice started dying), we infected TLR2 KO and WT mice with <italic>S. pneumoniae</italic> PLN and determined bacterial loads in whole lung homogenates at 24, 48 and 72 h thereafter (<xref ref-type="fig" rid="fig02">Fig. 2B</xref>). Whereas the bacterial burdens were not significantly different between TLR2 KO and WT mice 24 h post infection, at 48 and 72 h TLR2 KO displayed significantly higher bacterial loads in their lungs than WT mice (both <italic>P</italic> &#x0003c; 0.05). Remarkably, whereas <italic>S. pneumoniae</italic> PLN did not further grow in the lungs of WT mice from 24 h after infection onward, which is in line with a previous investigation (<xref ref-type="bibr" rid="b9">Canvin <italic>et al</italic>., 1995</xref>), the bacterial load increased more than 10-fold in lungs of TLR2 KO mice between 24 and 72 h after inoculation. Hence, these data show that TLR2 serves to limit the growth of <italic>S. pneumoniae</italic> PLN during pneumonia.</p><fig id="fig02" position="float"><label>Fig. 2</label><caption><p>TLR2 limits outgrowth of pneumolysin-deficient <italic>S. pneumoniae</italic> PLN. Survival (A) and bacterial outgrowth (B) of WT mice (closed symbols or bars) and TLR2 KO mice (open symbols or bars) with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> PLN. Mortality was assessed four times daily for 14 days (<italic>n</italic> = 13 per group). Bacterial loads in WT mice and TLR2 KO mice were determined 24, 48 and 72 h after infection. Data of bacterial loads are mean &#x000b1; SEM (<italic>n</italic> = 7&#x02013;8 per group at each time point) *<italic>P</italic> &#x0003c; 0.05 versus WT mice.</p></caption><graphic xlink:href="cmi0010-0237-f2"/></fig></sec><sec><title>Toll-like receptor 2 (TLR2) deficiency reduces lung inflammation induced by <italic>S. pneumoniae</italic> PLN</title><p>To further investigate the role of TLR2 during infection with <italic>S. pneumoniae</italic> PLN, we determined TNF-&#x003b1;, IL-1&#x003b2;, IL-10, MIP-2, KC and MPO levels in whole lung homogenates obtained 24, 48 and 72 h after inoculation (<xref ref-type="table" rid="tbl2">Table 2</xref>). At 24 h post infection, pulmonary cytokine and chemokine levels were lower in TLR2 KO mice, significantly so for IL-1&#x003b2; (<italic>P</italic> &#x0003c; 0.05). In addition, lung MPO levels were lower in TLR2 KO mice at this time point (<italic>P</italic> &#x0003c; 0.05). In contrast, at 48 and 72 h after infection, when TLR2 KO mice displayed higher bacterial burdens in their lungs, the pulmonary concentrations of cytokines, chemokines and MPO did not differ between TLR2 KO and WT mice. Histopathological analyses of lung tissue slides demonstrated reduced lung inflammation in TLR2 KO mice at 24 h, but increased lung inflammation at 48 and 72 h (<xref ref-type="table" rid="tbl2">Table 2</xref>). Representative lung tissue slides from WT and TLR2 KO mice 24, 48 and 72 h after infection with <italic>S. pneumoniae</italic> PLN are shown in <xref ref-type="fig" rid="fig03">Fig. 3</xref>.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Parameters of lung inflammation in TLR2 KO and WT mice 24, 48 and 72 h after infection with pneumolysin-deficient <italic>S. pneumoniae</italic> PLN.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">24 h</th><th align="center" colspan="2" rowspan="1">48 h</th><th align="center" colspan="2" rowspan="1">72 h</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><hr/></th><th align="center" colspan="2" rowspan="1"><hr/></th><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">325 &#x000b1; 77</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">295 &#x000b1; 87</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">195 &#x000b1; 34</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">195 &#x000b1; 34</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">506 &#x000b1; 114</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">522 &#x000b1; 163</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2414 &#x000b1; 519</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">903 &#x000b1; 496<xref ref-type="table-fn" rid="tf2-1">*</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">552 &#x000b1; 215</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">802 &#x000b1; 200</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1724 &#x000b1; 638</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2092 &#x000b1; 956</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-10</td><td align="left" rowspan="1" colspan="1">BD</td><td align="left" rowspan="1" colspan="1">BD</td><td align="left" rowspan="1" colspan="1">BD</td><td align="left" rowspan="1" colspan="1">BD</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">135 &#x000b1; 27</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">153 &#x000b1; 63</td></tr><tr><td align="left" rowspan="1" colspan="1">MIP-2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2703 &#x000b1; 1033</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1956 &#x000b1; 1001</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1919 &#x000b1; 194</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2720 &#x000b1; 649</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1029 &#x000b1; 589</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1297 &#x000b1; 692</td></tr><tr><td align="left" rowspan="1" colspan="1">KC</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1781 &#x000b1; 791</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">600 &#x000b1; 158</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1700 &#x000b1; 980</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">610 &#x000b1; 188</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1385 &#x000b1; 323</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">958 &#x000b1; 391</td></tr><tr><td align="left" rowspan="1" colspan="1">MPO</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3173 &#x000b1; 391</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1666 &#x000b1; 411<xref ref-type="table-fn" rid="tf2-1">*</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1675 &#x000b1; 424</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2205 &#x000b1; 226</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2722 &#x000b1; 251</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2402 &#x000b1; 500</td></tr><tr><td align="left" rowspan="1" colspan="1">TLIS</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7.7 &#x000b1; 2.0</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3.1 &#x000b1; 1.2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">6.9 &#x000b1; 1.6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">11.9 &#x000b1; 2.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.6 &#x000b1; 0.9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8.7 &#x000b1; 0.8<xref ref-type="table-fn" rid="tf2-1">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Mice were intranasally infected with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> PLN; whole lung homogenates were obtained 24, 48 and 72 h thereafter. Data are means &#x000b1; SEM (<italic>n</italic> = 6&#x02013;8 per group).</p></fn><fn id="tf2-1"><label>*</label><p><italic>P</italic> &#x0003c; 0.05 versus WT mice.</p></fn><fn><p>TNF-&#x003b1;, IL-1&#x003b2;, IL-10, MIP-2 and KC values are in pg ml<sup>&#x02212;1</sup>; MPO values are in ng ml<sup>&#x02212;1</sup>; TLIS (total lung inflammation score) in arbitrary units.</p></fn><fn><p>BD, below detection limit.</p></fn></table-wrap-foot></table-wrap><fig id="fig03" position="float"><label>Fig. 3</label><caption><p>Lung histology in WT and TLR2 KO mice after infection with <italic>S. pneumoniae</italic> PLN. Representative lung tissue slides from WT mice (A, C and E) and TLR2 KO mice (B, D and F) after infection with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> PLN. Mice were sacrificed after 24 h (A and B), 48 h (C and D) or 72 h (E and F). HE staining: magnification 4&#x000d7;.</p></caption><graphic xlink:href="cmi0010-0237-f3"/></fig></sec><sec><title>Toll-like receptor 2 (TLR2) deficiency strongly impairs the early inflammatory response to both <italic>S. pneumoniae</italic> D39 and <italic>S. pneumoniae</italic> PLN</title><p>The role of TLR2 in lung inflammation later in the course of pneumonia could have been obscured by the growing bacterial load in TLR2 KO mice (that is, at 48 and 72 h after infection, TLR2 deficiency could be compensated for by the higher bacterial load, providing a more potent proinflammatory stimulus via TLR2-independent pathways). An earlier study performed at our laboratory has shown an important role for TLR2 in the early host defence against <italic>S. pneumoniae</italic> pneumonia using serotype 3 (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). TLR2 could also be more important for the early host inflammatory response to <italic>S. pneumoniae</italic> with serotype 2. Thus, we intranasally inoculated TLR2 KO and WT mice with <italic>S. pneumoniae</italic> D39 or <italic>S. pneumoniae</italic> PLN and evaluated their response to the infection 6 h later (<xref ref-type="table" rid="tbl3">Table 3</xref>). The bacterial loads in lungs of TLR2 KO mice and WT mice were similar at this early time point during infection with <italic>S. pneumoniae</italic> D39 or <italic>S. pneumoniae</italic> PLN. Interestingly, compared with WT mice, TLR2 KO mice showed a strongly reduced capacity to respond to both <italic>S. pneumoniae</italic> D39 and <italic>S. pneumoniae</italic> PLN; the lung concentrations of TNF-&#x003b1;, IL-1&#x003b2;, MIP-2 and KC were much lower in TLR2 KO mice (<italic>P</italic> &#x0003c; 0.05 to <italic>P</italic> &#x0003c; 0.001) (<xref ref-type="table" rid="tbl3">Table 3</xref>). In addition, histopathological analyses of lung tissue slides demonstrated a significantly reduced inflammation in lungs of TLR2 KO mice 6 h after infection with <italic>S. pneumoniae</italic> D39 or <italic>S. pneumoniae</italic> PLN (<xref ref-type="fig" rid="fig04">Fig. 4</xref>). Of note, some inflammatory responses to <italic>S. pneumoniae</italic> PLN were more strongly reduced in TLR2 KO mice than the inflammatory responses to <italic>S. pneumoniae</italic> D39. For KC, MIP-2 and TNF-&#x003b1;, there was a significant interaction (<italic>P</italic> &#x0003c; 0.001, <italic>P</italic> = 0.034 and <italic>P</italic> = 0.007, respectively); the effect of the pneumococcal strain used depended on the mouse strain. In particular, whereas in WT mice <italic>S. pneumoniae</italic> D39 and PLN induced a similar early TNF-&#x003b1; response in the lungs, the pulmonary levels of this crucially protective cytokine in the early response to pneumococcal pneumonia (<xref ref-type="bibr" rid="b31">van der Poll <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="b32">Rijneveld <italic>et al</italic>., 2001</xref>) were more than 4-fold lower in TLR2 KO mice after infection with <italic>S. pneumoniae</italic> PLN versus 2-fold lower after inoculation with <italic>S. pneumoniae</italic> D39. In addition, whereas overall <italic>S. pneumoniae</italic> PLN elicited less profound histopathological alterations in lung tissue than <italic>S. pneumoniae</italic> D39, the difference in total lung histology scores between TLR2 KO and WT mice was especially clear after infection with the pneumolysin-deficient strain.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p>Role of TLR2 in the early inflammatory response in the lungs after infection with <italic>S. pneumoniae</italic> D39 or PLN.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">D39</th><th align="center" colspan="2" rowspan="1">PLN</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><hr/></th><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">TLR2 KO</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">cfu</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">6.5 &#x000b1; 1.4 &#x000d7; 10<sup>6</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.5 &#x000b1; 1.3 &#x000d7; 10<sup>6</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">13.2 &#x000b1; 1.3 &#x000d7; 10<sup>6</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10.6 &#x000b1; 1.8 &#x000d7; 10<sup>6</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9 781 &#x000b1; 780</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4 656 &#x000b1; 375<xref ref-type="table-fn" rid="tf3-2">**</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9 124 &#x000b1; 1 203</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2270 &#x000b1; 236<xref ref-type="table-fn" rid="tf3-2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5 754 &#x000b1; 714</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3 566 &#x000b1; 348<xref ref-type="table-fn" rid="tf3-1">*</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">18 963 &#x000b1; 2 522</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8716 &#x000b1; 1939<xref ref-type="table-fn" rid="tf3-1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">IL-10</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">31 &#x000b1; 2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">32 &#x000b1; 3</td><td align="left" rowspan="1" colspan="1">BD</td><td align="left" rowspan="1" colspan="1">BD</td></tr><tr><td align="left" rowspan="1" colspan="1">MIP-2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">42 193 &#x000b1; 2 529</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">23 855 &#x000b1; 3 396<xref ref-type="table-fn" rid="tf3-3">***</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9 114 &#x000b1; 1 112</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2643 &#x000b1; 505<xref ref-type="table-fn" rid="tf3-2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">KC</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">61 120 &#x000b1; 2 879</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">23 266 &#x000b1; 3 124<xref ref-type="table-fn" rid="tf3-3">***</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">16 776 &#x000b1; 2 314</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4783 &#x000b1; 1352<xref ref-type="table-fn" rid="tf3-2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">MPO</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">76.7 &#x000b1; 9.3</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">41.6 &#x000b1; 3.4<xref ref-type="table-fn" rid="tf3-1">*</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">15.5 &#x000b1; 3.4</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">12.4 &#x000b1; 4.0</td></tr><tr><td align="left" rowspan="1" colspan="1">TLIS</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">18.4 &#x000b1; 0.5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">15.1 &#x000b1; 0.8<xref ref-type="table-fn" rid="tf3-1">*</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9.5 &#x000b1; 0.9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.3 &#x000b1; 1.3<xref ref-type="table-fn" rid="tf3-1">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Mice were intranasally infected with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> D39 or PLN, and whole lung homogenates were obtained 6 h later. Data are means &#x000b1; SEM (<italic>n</italic> = 8 per group).</p></fn><fn id="tf3-1"><label>*</label><p><italic>P</italic> &#x0003c; 0.05 versus WT mice.</p></fn><fn id="tf3-2"><label>**</label><p><italic>P</italic> &#x0003c; 0.001 versus WT mice.</p></fn><fn id="tf3-3"><label>***</label><p><italic>P</italic> &#x0003c; 0.01 versus WT mice.</p></fn><fn><p>TNF-&#x003b1;, IL-1&#x003b2;, IL-10, MIP-2 and KC values are in pg ml<sup>&#x02212;1</sup>; cfu values are in cfu ml<sup>&#x02212;1</sup> lung; MPO levels are in &#x003bc;g ml<sup>&#x02212;1</sup>; TLIS (total lung inflammation score) in arbitrary units.</p></fn><fn><p>BD, below detection limit.</p></fn></table-wrap-foot></table-wrap><fig id="fig04" position="float"><label>Fig. 4</label><caption><p>Reduced lung inflammation in TLR2 KO mice early after infection with <italic>S. pneumoniae</italic> D39 or <italic>S. pneumoniae</italic> PLN. Representative lung tissue slides from WT mice (A and C) and TLR2 KO mice (B and D) 6 h after infection with 5 &#x000d7; 10<sup>7</sup> cfu <italic>S. pneumoniae</italic> D39 (A and B) or <italic>S. pneumoniae</italic> PLN (C and D). HE staining: magnification 4&#x000d7;. Insets show Ly-6G staining.</p></caption><graphic xlink:href="cmi0010-0237-f4"/></fig></sec></sec><sec><title>Discussion</title><p>Pneumolysin is an essential virulence factor of <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="b15">Hirst <italic>et al</italic>., 2004</xref>). Recent studies have identified TLR4 as a recognition receptor for pneumolysin in the respiratory tract (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>). The interaction between pneumolysin and TLR4 was found to contribute to a protective immune response to <italic>S. pneumoniae</italic>, in particular in a model of upper airway colonization (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>) and to a lesser extent during experimental lower respiratory tract infection (<xref ref-type="bibr" rid="b7">Branger <italic>et al</italic>., 2004</xref>). Although the pneumococcus expresses several potent TLR2 ligands (<xref ref-type="bibr" rid="b39">Yoshimura <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b14">Han <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b36">Schroder <italic>et al</italic>., 2003</xref>), our laboratory previously could not demonstrate a decisive role for TLR2 in host defence against pneumococcal pneumonia (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). We here hypothesized that in the absence of TLR2, <italic>S. pneumoniae</italic> could still be sensed by the immune system through an interaction between pneumolysin and TLR4. The experiments described herein support this hypothesis: whereas the growth of WT pneumococci occurred to a similar extent in TLR2 KO and WT mice, the pneumolysin-deficient <italic>S. pneumoniae</italic> PLN strain only grew out in TLR2 KO mice. These data suggest that pneumolysin-induced TLR4 signalling can compensate for TLR2 deficiency during respiratory tract infection with <italic>S. pneumoniae</italic>.</p><p>In a series of elegant experiments Malley and coworkers demonstrated that pneumolysin is a ligand for TLR4 (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>). Purified pneumolysin was shown to activate cells via a TLR4-dependent, TLR2-independent pathway, accomplished by a physical interaction between pneumolysin and TLR4 (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>). Interestingly, pneumolysin induced proinflammatory responses in primary macrophages in synergy with TLR2 ligands derived from <italic>S. pneumoniae</italic>, in particular peptidoglycan and whole pneumococcal cell walls (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>), suggesting that during infection with intact pneumococci, the combined action of TLR4 and TLR2 may facilitate an optimal innate immune response. Such roles for these two distinct TLRs is further corroborated by findings that, in the human embryonic kidney cell line 293, transfection of either TLR2 or TLR4 conferred responsiveness to <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="b23">Koedel <italic>et al</italic>., 2003</xref>). Thus far, the isolated roles of either TLR4 or TLR2 in host defence against <italic>S. pneumoniae in vivo</italic> have been investigated in a number of studies. The most dramatic phenotype was reported in the original publication by Malley <italic>et al</italic>. (<xref ref-type="bibr" rid="b24">Malley <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b37">Srivastava <italic>et al</italic>., 2005</xref>), showing that C3H/HeJ mice, which carry a loss-of-function <italic>tlr4</italic> mutation, are more susceptible to pneumococcal colonization after nasopharyngeal challenge, eventually resulting in invasive infection, bacteremia and death. Our laboratory found a more modest protective role for TLR4 during lower respiratory tract infection by <italic>S. pneumoniae</italic>, as reflected by a reduced survival and a slightly enhanced bacterial outgrowth after intranasal infection of C3H/HeJ mice with a relatively low infectious dose (<xref ref-type="bibr" rid="b7">Branger <italic>et al</italic>., 2004</xref>). TLR2 KO mice demonstrated an increased disease severity together with a moderately enhanced bacterial growth in the central nervous system during meningitis induced by intracisternal injection of pneumococci (<xref ref-type="bibr" rid="b12">Echchannaoui <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b23">Koedel <italic>et al</italic>., 2003</xref>). In contrast, our group could not demonstrate a protective role for TLR2 in pneumonia caused by <italic>S. pneumoniae</italic>, showing similar bacterial multiplication and lethality after intranasal infection of TLR2 KO and WT mice (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). A limited role for TLR2 during infection with WT <italic>S. pneumoniae</italic> is further supported by a recent study in which intact pneumococci were administered intraperitoneally (<xref ref-type="bibr" rid="b20">Khan <italic>et al</italic>., 2005</xref>), although TLR2 KO mice displayed a modestly slower clearance of <italic>S. pneumoniae</italic> from their nasopharynx in another investigation (<xref ref-type="bibr" rid="b33">van Rossum <italic>et al</italic>., 2005</xref>). Altogether these studies suggest that TLR2 at best plays a modest role in host defence against <italic>S. pneumoniae</italic> airway infection, and led us to hypothesize that intact TLR4 signalling through pneumolysin may balance the lack of TLR2 signalling. We tested this hypothesis by infecting TLR2 KO mice with pneumolysin-deficient <italic>S. pneumoniae</italic>, arguing that these bacteria, devoid of a major TLR4 ligand, predominantly express TLR2 ligands. Indeed, whereas antibacterial defence in TLR2 KO mice was unimpaired during infection with <italic>S. pneumoniae</italic> D39, infection with <italic>S. pneumoniae</italic> PLN resulted in enhanced outgrowth in these mice. If our hypothesis is correct, inoculation of WT <italic>S. pneumoniae</italic> D39 in TLR2 &#x000d7; 4 double KO mice should result in a comparable setting as pneumolysin-deficient <italic>S. pneumoniae</italic> in TLR2 KO mice, i.e. absence of TLR2 <italic>and</italic> TLR4 signalling. Our first preliminary results show that indeed this is the case: growth of WT <italic>S. pneumoniae</italic> D39 was significantly higher in the lungs of TLR2 &#x000d7; 4 double KO mice compared with WT mice 48 h after inoculation (data not shown). In line, <xref ref-type="bibr" rid="b1">Albiger <italic>et al</italic>. (2005)</xref> recently showed that mice deficient of the TLR2- and TLR4-common intracellular adaptor molecule MyD88 also displayed an enhanced bacterial outgrowth in MyD88 KO mice compared with WT mice.</p><p>The early inflammatory response is an essential component of host defence in this model of pneumococcal pneumonia, as documented by previous studies in which the early cytokine response was inhibited (<xref ref-type="bibr" rid="b31">van der Poll <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="b32">Rijneveld <italic>et al</italic>., 2001</xref>). Although TLR2 KO mice displayed a reduced inflammatory response 6 h after infection with either <italic>S. pneumoniae</italic> D39 or PLN, some responses were more strongly diminished after infection with the pneumolysin-deficient strain. This was in particular true for the early TNF-&#x003b1; response. Considering that especially low TNF-&#x003b1; concentrations in the lungs early after induction of pneumococcal pneumonia are important for limiting the growth of <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="b31">van der Poll <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="b32">Rijneveld <italic>et al</italic>., 2001</xref>), this differential response may have contributed to the enhanced growth of <italic>S. pneumoniae</italic> PLN in TLR2 KO mice. In addition, mediators other than measured in this study could contribute to this finding. Of note, TLR2 KO mice still display an induction of cytokines and chemokines when infected with pneumolysin-deficient <italic>S. pneumoniae</italic>, suggesting that other pattern recognition receptors contribute to this response, In this respect, the recent finding that TLR9 can recognize pneumococcall DNA is of relevance (<xref ref-type="bibr" rid="b25">Mogensen <italic>et al</italic>., 2006</xref>). Moreover, although histopathological analysis of lung tissue showed diminished lung inflammation in TLR2 KO mice during the early course of infection with <italic>S. pneumoniae</italic> PLN, which is in line with a TLR2-dependent immune response, during the later phase of pneumonia lung inflammation of TLR2 KO mice was enhanced compared with WT mice, which corresponded with the higher bacterial loads. This finding suggests that, in the presence of a high bacterial burden, <italic>S. pneumoniae</italic> PLN is able to elicit significant lung inflammation via a TLR2-independent route. Hence, it is conceivable that the early recognition of <italic>S. pneumoniae</italic> and, thereby, the initial inflammatory response in the airways at least in part are mediated by TLR2, through an interaction between this receptor and the various TLR2 ligands expressed by the pneumococcus (<xref ref-type="bibr" rid="b39">Yoshimura <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b14">Han <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="b36">Schroder <italic>et al</italic>., 2003</xref>), but that, during a more established infection with a higher bacterial burden, the TLR2-induced inflammation is &#x02018;overruled&#x02019; by other pathways stimulated by TLR2-independent pneumococcal antigens.</p><p>Our results exemplify the complex interactions at play during the first encounter between the host, expressing multiple pattern recognition receptors, and an intact pathogen, expressing multiple virulence factors and pathogen-associated molecular patterns. Whereas during infection of TLR2 KO mice with WT pneumococci, the interaction between TLR4 and pneumolysin apparently is sufficient to maintain an adequate immune response, during infection of TLR2 KO mice with pneumolysin-deficient <italic>S. pneumoniae</italic>, the absence of the interaction between pneumococcal TLR2 ligands, such as lipoteichoic acid and peptidoglycan, cannot be compensated for by the TLR4 pneumolysin-mediated immune response. As such, our data demonstrate redundancy at both the microbial site and the site of the host during airway infection by <italic>S. pneumoniae</italic>.</p></sec><sec sec-type="methods"><title>Experimental procedures</title><sec><title>Animals</title><p>C57BL/6 WT mice were purchased from Charles Rivers (Maastricht, the Netherlands). TLR2 KO mice (<xref ref-type="bibr" rid="b38">Takeuchi <italic>et al</italic>., 1999</xref>), backcrossed to a C57BL/6 genetic background six times, were bred in the animal facility of the Academic Medical Center in Amsterdam. Sex- and age-matched (10&#x02013;12 weeks) mice were used in all experiments. All experiments were approved by the Animal Care and Use Committee of the University of Amsterdam.</p></sec><sec><title>Design</title><p>The experimental procedures to induce pneumonia have been described earlier (<xref ref-type="bibr" rid="b7">Branger <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b11">Dessing <italic>et al</italic>., 2007</xref>). <italic>S. pneumoniae</italic> serotype 2 (strain D39) and isogenic pneumolysin-deficient <italic>S. pneumoniae</italic> (strain PLN) (<xref ref-type="bibr" rid="b6">Berry <italic>et al</italic>., 1989</xref>) were grown for 5 h to mid-logarithmic phase at 37&#x000b0;C using Todd&#x02013;Hewitt broth (Difco, Detroit, MI), harvested by centrifugation at 1500 <italic>g</italic> for 15 min, and washed twice in sterile isotonic saline. A total of 50 &#x003bc;l containing 5 &#x000d7; 10<sup>7</sup> colony-forming units (cfu) were inoculated intranasally in mice which were lightly anesthetized by inhalation of isoflurane (Upjohn, Ede, the Netherlands). Mice were killed 6, 24 or 48 h after infection with <italic>S. pneumoniae</italic> D39, or 6, 24, 48 or 72 h after infection with <italic>S. pneumoniae</italic> PLN. In separate studies, survival of mice was determined during a 2 week follow-up.</p></sec><sec><title>Measurement of bacterial loads</title><p>Lung bacterial loads were determined as described earlier (<xref ref-type="bibr" rid="b7">Branger <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b11">Dessing <italic>et al</italic>., 2007</xref>). Briefly, mice were sacrificed, and blood and lungs were collected. Lungs were homogenized at 4&#x000b0;C in 5 vols of sterile isotonic saline with a tissue homogenizer (Biospect Products, Bartlesville, OK). Serial 10-fold dilutions in sterile isotonic saline were made from these homogenates (and blood), and 50 &#x003bc;l vols were plated onto sheep-blood agar plates and incubated overnight at 37&#x000b0;C and 5% CO<sub>2</sub>.</p></sec><sec><title>Histology</title><p>Lungs for histology were fixed in 10% formalin and embedded in paraffin. Four millimetre sections were stained with haematoxylin and eosin (HE) and analysed by a pathologist who was blinded for groups. To score lung inflammation and damage, the entire lung surface was analysed with respect to the following parameters: bronchitis, oedema, interstitial inflammation, intra-alveolar inflammation, pleuritis and endothelialitis. Each parameter was graded on a scale of 0&#x02013;4, with 0 as &#x02018;absent&#x02019; and 4 as &#x02018;severe&#x02019;. The total &#x02018;lung inflammation score&#x02019; was expressed as the sum of the scores for each parameter, the maximum being 24. Granulocyte staining was performed as described earlier by Ly-6G staining (<xref ref-type="bibr" rid="b11">Dessing <italic>et al</italic>., 2007</xref>).</p></sec><sec><title>Assays</title><p>Lung homogenates were prepared as described earlier (<xref ref-type="bibr" rid="b21">Knapp <italic>et al</italic>., 2004</xref>). MPO was measured by ELISA (HyCult, Uden, the Netherlands). TNF-&#x003b1;, IL-1&#x003b2;, IL-10, MIP-2 and KC were measured by ELISA (R and D Systems, Abingdon, UK).</p></sec><sec><title>Statistical analysis</title><p>Statistics were performed with GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, CA). All data are given as means &#x000b1; SEM. Differences between groups were analysed using Mann&#x02013;Whitney <italic>U</italic>-test. For survival analyses, Kaplan-Meier analysis followed by log rank test was performed. To analyse the effect of the used bacterial strains and their interactions in more detail in WT and TLR2 KO mice 6 h after inoculation, results of the groups were compared using an <sc>anova</sc>. Data were checked for normal distribution and equal variances using the residuals. All variables were normally distributed, but MIP-2, IL-1&#x003b2; and TNF-&#x003b1; were ln-transformed to obtain equal variances. Later statistics was performed using <sc>spss</sc> statistical software version 12.0.1 (SPSS, Chicago, IL). A value of <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec></body><back><ack><p>We would like to thank Joost Daalhuisen and Marieke 10 Brink for technical assistance during the animal experiments, Regina de Beer for preparations of lung sections, and Michael Tanck for statistical advice.</p></ack><ref-list><title>References</title><ref id="b1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albiger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice</article-title><source>Cell Microbiol</source><year>2005</year><volume>7</volume><fpage>1603</fpage><lpage>1615</lpage><pub-id pub-id-type="pmid">16207247</pub-id></citation></ref><ref id="b2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alouf</surname><given-names>JE</given-names></name></person-group><article-title>Cholesterol-binding cytolytic protein toxins</article-title><source>Int J Med Microbiol</source><year>2000</year><volume>290</volume><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">11111910</pub-id></citation></ref><ref id="b3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benton</surname><given-names>KA</given-names></name></person-group><article-title>A pneumolysin-negative mutant of <italic>Streptococcus pneumoniae</italic> causes chronic bacteremia rather than acute sepsis in mice</article-title><source>Infect Immun</source><year>1995</year><volume>63</volume><fpage>448</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">7822009</pub-id></citation></ref><ref id="b4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>JM</given-names></name></person-group><article-title>Treatment of community-acquired pneumonia &#x02013; IDSA guidelines. Infectious Diseases Society of America</article-title><source>Chest</source><year>1999</year><volume>115</volume><fpage>9S</fpage><lpage>13S</lpage><pub-id pub-id-type="pmid">10084453</pub-id></citation></ref><ref id="b5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>AM</given-names></name></person-group><article-title>Additive attenuation of virulence of <italic>Streptococcus pneumoniae</italic> by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">10603379</pub-id></citation></ref><ref id="b6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>AM</given-names></name></person-group><article-title>Reduced virulence of a defined pneumolysin-negative mutant of <italic>Streptococcus pneumoniae</italic></article-title><source>Infect Immun</source><year>1989</year><volume>57</volume><fpage>2037</fpage><lpage>2042</lpage><pub-id pub-id-type="pmid">2731982</pub-id></citation></ref><ref id="b7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>788</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">14742522</pub-id></citation></ref><ref id="b8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>GD</given-names><suffix>Jr</suffix></name></person-group><article-title>Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia</article-title><source>Chest</source><year>1999</year><volume>115</volume><fpage>14S</fpage><lpage>18S</lpage><pub-id pub-id-type="pmid">10084454</pub-id></citation></ref><ref id="b9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Canvin</surname><given-names>JR</given-names></name></person-group><article-title>The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus</article-title><source>J Infect Dis</source><year>1995</year><volume>172</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">7797901</pub-id></citation></ref><ref id="b10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cockeran</surname><given-names>R</given-names></name></person-group><article-title>Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro</article-title><source>J Infect Dis</source><year>2002</year><volume>186</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">12195386</pub-id></citation></ref><ref id="b11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dessing</surname><given-names>MC</given-names></name></person-group><article-title>CD14 facilitates invasive respiratory tract infection by <italic>Streptococcus pneumoniae</italic></article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>175</volume><fpage>604</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">17185649</pub-id></citation></ref><ref id="b12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Echchannaoui</surname><given-names>H</given-names></name></person-group><article-title>Toll-like receptor 2-deficient mice are highly susceptible to <italic>Streptococcus pneumoniae</italic> meningitis because of reduced bacterial clearing and enhanced inflammation</article-title><source>J Infect Dis</source><year>2002</year><volume>186</volume><fpage>798</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">12198614</pub-id></citation></ref><ref id="b13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>RJ</given-names></name></person-group><article-title>Pore-forming toxins</article-title><source>Cell Mol Life Sci</source><year>2002</year><volume>59</volume><fpage>832</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">12088283</pub-id></citation></ref><ref id="b14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SH</given-names></name></person-group><article-title>Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>5541</fpage><lpage>5548</lpage><pub-id pub-id-type="pmid">14500472</pub-id></citation></ref><ref id="b15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirst</surname><given-names>RA</given-names></name></person-group><article-title>The role of pneumolysin in pneumococcal pneumonia and meningitis</article-title><source>Clin Exp Immunol</source><year>2004</year><volume>138</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">15498026</pub-id></citation></ref><ref id="b16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houldsworth</surname><given-names>S</given-names></name></person-group><article-title>Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes</article-title><source>Infect Immun</source><year>1994</year><volume>62</volume><fpage>1501</fpage><lpage>1503</lpage><pub-id pub-id-type="pmid">8132361</pub-id></citation></ref><ref id="b17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jedrzejas</surname><given-names>MJ</given-names></name></person-group><article-title>Pneumococcal virulence factors: structure and function</article-title><source>Microbiol Mol Biol Rev</source><year>2001</year><volume>65</volume><fpage>187</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">11381099</pub-id></citation></ref><ref id="b18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadioglu</surname><given-names>A</given-names></name></person-group><article-title>Upper and lower respiratory tract infection by <italic>Streptococcus pneumoniae</italic> is affected by pneumolysin deficiency and differences in capsule type</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>2886</fpage><lpage>2890</lpage><pub-id pub-id-type="pmid">12010976</pub-id></citation></ref><ref id="b19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name></person-group><article-title>Pathogen recognition with Toll-like receptors</article-title><source>Curr Opin Immunol</source><year>2005</year><volume>17</volume><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">15950447</pub-id></citation></ref><ref id="b20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AQ</given-names></name></person-group><article-title>Both innate immunity and type 1 humoral immunity to <italic>Streptococcus pneumoniae</italic> are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">15618166</pub-id></citation></ref><ref id="b21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>S</given-names></name><etal/></person-group><article-title>Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>3132</fpage><lpage>3138</lpage><pub-id pub-id-type="pmid">14978119</pub-id></citation></ref><ref id="b22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>S</given-names></name></person-group><article-title>Pneumonia models and innate immunity to respiratory bacterial pathogens</article-title><source>Shock</source><year>2005</year><volume>24</volume><issue>Suppl. 1</issue><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">16374367</pub-id></citation></ref><ref id="b23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koedel</surname><given-names>U</given-names></name></person-group><article-title>Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>438</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">12496429</pub-id></citation></ref><ref id="b24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malley</surname><given-names>R</given-names></name><etal/></person-group><article-title>Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>1966</fpage><lpage>1971</lpage><pub-id pub-id-type="pmid">12569171</pub-id></citation></ref><ref id="b25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>TH</given-names></name></person-group><article-title>Live <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic>, <italic>and Neisseria meningitidis</italic> activate the inflammatory response through Toll-like receptors 2,4, and 9 in species-specific patterns</article-title><source>J Leukoc Biol</source><year>2006</year><volume>80</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">16731773</pub-id></citation></ref><ref id="b26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>TA</given-names></name></person-group><article-title>Cytokine immunotherapy during bacterial pneumonia: from benchtop to bedside</article-title><source>Semin Respir Infect</source><year>2001</year><volume>16</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11309710</pub-id></citation></ref><ref id="b27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>GK</given-names></name></person-group><article-title>Innate immunity and the pneumococcus</article-title><source>Microbiology</source><year>2006</year><volume>152</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">16436416</pub-id></citation></ref><ref id="b28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paton</surname><given-names>JC</given-names></name></person-group><article-title>The contribution of pneumolysin to the pathogenicity of <italic>Streptococcus pneumoniae</italic></article-title><source>Trends Microbiol</source><year>1996</year><volume>4</volume><fpage>103</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">8868088</pub-id></citation></ref><ref id="b29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paton</surname><given-names>JC</given-names></name></person-group><article-title>Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin</article-title><source>Infect Immun</source><year>1983</year><volume>41</volume><fpage>1212</fpage><lpage>1216</lpage><pub-id pub-id-type="pmid">6885160</pub-id></citation></ref><ref id="b30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pikis</surname><given-names>A</given-names></name></person-group><article-title>Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area</article-title><source>Arch Pediatr Adolesc Med</source><year>1995</year><volume>149</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">7827656</pub-id></citation></ref><ref id="b31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><article-title>Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>155</volume><fpage>603</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">9032201</pub-id></citation></ref><ref id="b32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rijneveld</surname><given-names>AW</given-names></name></person-group><article-title>TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia</article-title><source>J Immunol</source><year>2001</year><volume>167</volume><fpage>5240</fpage><lpage>5246</lpage><pub-id pub-id-type="pmid">11673538</pub-id></citation></ref><ref id="b33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Rossum</surname><given-names>AM</given-names></name></person-group><article-title>Host and bacterial factors contributing to the clearance of colonization by <italic>Streptococcus pneumoniae</italic> in a murine model</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>7718</fpage><lpage>7726</lpage><pub-id pub-id-type="pmid">16239576</pub-id></citation></ref><ref id="b34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rubins</surname><given-names>JB</given-names></name></person-group><article-title>Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia</article-title><source>J Clin Invest</source><year>1995</year><volume>95</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">7814608</pub-id></citation></ref><ref id="b35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>JR</given-names></name></person-group><article-title>Antibiotic-resistant pneumococci</article-title><source>Pediatr Clin North Am</source><year>1995</year><volume>42</volume><fpage>519</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">7761139</pub-id></citation></ref><ref id="b36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>NW</given-names></name><etal/></person-group><article-title>Lipoteichoic acid (LTA) of <italic>Streptococcus pneumoniae</italic> and <italic>Staphylococcus aureus</italic> activates immune cells via Toll-like receptor (TLR) -2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>15587</fpage><lpage>15594</lpage><pub-id pub-id-type="pmid">12594207</pub-id></citation></ref><ref id="b37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><etal/></person-group><article-title>The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>6479</fpage><lpage>6487</lpage><pub-id pub-id-type="pmid">16177320</pub-id></citation></ref><ref id="b38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O</given-names></name><etal/></person-group><article-title>Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components</article-title><source>Immunity</source><year>1999</year><volume>11</volume><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">10549626</pub-id></citation></ref><ref id="b39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>A</given-names></name></person-group><article-title>Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2</article-title><source>J Immunol</source><year>1999</year><volume>163</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10384090</pub-id></citation></ref></ref-list></back></article> 